Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02417025 · ClinicalTrials.gov registry record · NA

Innovative Delivery of Evidence Based Psychotherapy to Women With Military Sexual Trauma

A NA study, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
136
Enrollment target

NCT02417025: Completed NA study, sponsored by Medical University of South Carolina.

NCT02417025 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 136 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02417025, a NA study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
136 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether a scientifically validated treatment for Posttraumatic Stress Disorder (PTSD) called Prolonged Exposure (PE) can be delivered effectively to Veterans with Military Sexual Trauma (MST) related PTSD using videoconferencing technology, which allows a therapist and patient who are not in the same room as one another to communicate. The investigators are interested in learning if this form of mental health service delivery is an acceptable alternative to traditional face-to-face therapy delivered with the therapist in the same room as the patient. This study is being conducted at the Charleston VA Medical Center and surrounding Community-Based Outpatient Clinics (CBOCs), and will involve approximately 100 female participants.

Interventions

  • BEHAVIORAL PE

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2014-08
Est. Completion 2019-11-29
Phase NA

What the finished NCT02417025 record still lists

NCT02417025 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 1 intervention - of which PE is the first listed.

NCT02417025 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02417025 about?

NCT02417025 is a clinical study titled "Innovative Delivery of Evidence Based Psychotherapy to Women With Military Sexual Trauma". The purpose of this study is to determine whether a scientifically validated treatment for Posttraumatic Stress Disorder (PTSD) called Prolonged Exposure (PE) can be delivered effectively to Veterans with Military Sexual Trauma (MST) related PTSD using videoconferencing technology, which allows a th...

What is the current status of trial NCT02417025?

This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2014-08. Estimated completion is 2019-11-29.

What interventions are being tested in trial NCT02417025?

The interventions under investigation include: PE (BEHAVIORAL).

Who is sponsoring clinical trial NCT02417025?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02417025's enrollment target sits among peer trials

136 722nd of 2000 higher than 1,275 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01555892 · 136 participants · Phase 1

    Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

  • NCT03216525 · 136 participants · Phase 3

    Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

  • NCT04476901 · 136 participants · Phase 2

    Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

  • NCT04603898 · 136 participants · NA

    Oxalate Formation From Ascorbic Acid

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02417025, the US trial registry maintained by the National Library of Medicine. NCT02417025 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.